相关实验视频
Updated: Jun 24, 2025

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.0K
卵巢癌的CAR-T疗法:最近的进展和未来的方向
Qianling Xin1, Yizhao Chen2, Xiaojing Sun1
1Anhui Women and Children's Medical Center, Hefei Maternal and Child Health Hospital, Hefei, China.
Biochemical pharmacology
|June 9, 2024
概括
基于化学抗原受体 (CAR) 的采用细胞疗法,包括CAR-T,CAR-NK和CAR-巨细胞 (CAR-M) 细胞,在治疗卵巢癌 (OC) 中表现有前途. 这些先进的免疫疗法为改善这种具有挑战性的妇科瘤患者存活率提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
背景情况:
- 卵巢癌 (OC) 由于高死亡率,治疗耐药性和复发而构成重大挑战.
- OC被认为是一种免疫性瘤,因此成为免疫治疗的目标.
- 目前的免疫疗法,如免疫检查点抑制剂,在OC中表现出有限的疗效.
研究的目的:
- 审查最近在CAR-T,CAR-NK和CAR-巨细胞 (CAR-M) 细胞治疗卵巢癌方面的进展.
- 讨论CAR的结构修改,以提高OC免疫疗法的有效性.
- 突出基于CAR的采用细胞疗法的新兴治疗机会,以改善OC患者的存活率.
主要方法:
- 对OC的CAR-T治疗进行的临床前和临床研究的综述.
- 对实体瘤中CAR-NK和CAR-M细胞潜力的研究分析,包括OC.
- 讨论CAR的结构修改,以提高效率.
主要成果:
- CAR-T疗法最初在血液性恶性瘤中取得了成功,目前正在为OC探索.
- CAR-NK和CAR-M疗法显示出治疗OC等固体瘤的巨大潜力.
- 目前正在进行的研究重点是优化CAR结构,以更好地针对OC和免疫反应.
结论:
- 基于CAR的收养细胞疗法代表了卵巢癌治疗的前沿.
- 进一步研究和开发CAR工程对于克服当前的局限性至关重要.
- 这些先进的免疫疗法有可能显著改善卵巢癌患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354

